Onco-Innovations Limited
ONNVF
$1.10
-$0.09-7.56%
OTC PK
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.16M | -7.69M | -5.99M | -- | -- |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.62M | 3.86M | 3.91M | -- | -- |
| Change in Net Operating Assets | -596.70K | -206.70K | -642.20K | -- | -- |
| Cash from Operations | -5.13M | -4.03M | -2.73M | -- | -- |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 5.60K | 5.60K | 72.20K | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 5.60K | 5.60K | 72.20K | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -18.20K | -18.20K | -18.20K | -- | -- |
| Issuance of Common Stock | 8.12M | 6.27M | 4.56M | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -250.90K | -120.20K | -120.20K | -- | -- |
| Cash from Financing | 5.60M | 4.36M | 3.12M | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 471.70K | 336.60K | 466.20K | -- | -- |